Angiotensin-converting enzyme inhibitors may offer superior protection against acute myocardial infarction compared to angiotensin receptor blockers due to their unique beneficial effects on prothrombotic processes and endothelial function.
Answers are grounded in this paper and cite their sources.
Morning ischemic events may reflect prothrombotic surges; hypothesis-generating for bradykinin or AT2/AT4 modulation.
Acute ischemic events occur most frequently at dawn and in the early hours of the morning. The development of these severe clinical events exhibits a temporal relationship with changes in various hemodynamic, prothrombotic, and hormonal processes. The authors highlight not only these relationships but also the potential protective effect of increased bradykinin levels and the inhibition of different angiotensin II (AT-II) receptors (AT2, AT4) against unfavorable prothrombotic influences, which-based on studies to date-decreases the risk of acute cardiovascular events. Comparisons are presented between the different effects of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers on factors that influence thrombus formation and myocardial infarction risk.
No takes yet. Share an insight, caveat, or question.
Dézsi et al. (2016) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: